Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Publication Ethics

Girls using a chemistry set together

Publication Ethics

Journal of the Pakistan Dental Association (JPDA) follows the uniform requirements for manuscripts submitted to Biomedical Journals as approved by the International Committee of Medical Journal Editors revision of December 20-17 available at http://www.icmje.org/icmje-recommendations.pdf.  The ethical declaration for JPDA is based on the ‘Code of Conduct’ guidelines by the Committee on Publication Ethics (COPE) available at www.publicationethics.org.

COPYRIGHT DECLARATION

Journal of Pakistan Dental Association is the (JPDA) the official scientific journal of Pakistan Dental Association (PDA). It is published quarterly. Whereas, the Dental News are its composer and publisher.  A double-blind peer review system is followed to ensure a high quality of publications. In addition to that, each publication undergoes a plagiarism check with Turnitin.

All rights are reserved. No part of this journal may be reproduced, stored in a retrieval system, transmitted in any form, or by any other means; electronic, mechanical, photocopying, recording or otherwise, except for internal or personal use, without the prior permission, in writing, from the Journal of Pakistan Dental Association.

All submissions are accompanied by a statement from the author that their paper has not been submitted for publication elsewhere nor has been published before. Also, that all authors have read the and approved the final draft for publication and bear full responsibility.

The publisher and editorial board shall not be held accountable for consequences resulting from misuse of information published in this journal. Whereas, the content published in the journal represents the opinions of author only and not that of publisher or editorial board, the editorial board reserves the right to amend or remove part or whole of manuscripts if deemed necessary.

PEER RERIEW PROCESS

1. In-House Review

Each submission undergoes an in-house review. In this step, scope of paper, plagiarism and completeness of obligatory documents is checked.

2. Peer Review

We follow a double-blind peer review. Our reviewers belong to national and international educational and research institutes. Each submission is sent to al-least two reviewers. The reviewers are given an average of three weeks to submit their report. The comments of reviewers are forwarded to authors and once revised manuscript is received from the authors, it is sent back to the original or a new set of reviewers for a re-review. Once a cycle of review and re-review is complete and reviewers are satisfied with the quality of manuscript, an acceptance is issued.

3. Malpractice Statement

Manuscripts, either published or under review will be withdrawn and rejected if a part or whole of it was determined to violate the publishing ethics guidelines such as multiple submission, fake claims of authorship, plagiarism, fraudulent use of data or the like. Moreover, such an author may be black listed and banned from future submission for a period determined by the editorial board.

4. Plagiarism Prevention

JPDA uses the standard software (Turnitin) to detect instances of overlapping and similar text in submitted manuscripts. The software checks content against a database of periodicals, the Internet, and a comprehensive articles database. It generates a similarity report, highlighting the percentage of overlap between the uploaded article and the published material. Any instance of content overlap is further scrutinized for suspected plagiarism according to the publisher’s Editorial Policies. JPDA allows an overall similarity of 19% for a manuscript to be considered for publication.

ETHICAL APPROVAL OF STUDIES AND INFORMED CONSENT

For human or animal experimental investigations, it is a prerequisite to provide a formal approval, by an appropriate institutional review board or ethics committee, which should be documented in the paper. For investigations undertaken on human subjects, the manner in which the informed consent was obtained from the study participants (i.e., oral or written) should be stated in the Methods section. All clinical investigations must be conducted according to the Declaration of Helsinki principles.

APPEALS AND COMPLAINTS

Authors who wish to make a complaint should refer it to the Editor-in-Chief of the journal. (editor@jpda.com.pk)

Complaints to the Publisher may be forwarded to irfan@medicalnewsgroup.com.pk

CONFLICT OF INTEREST

Financial and intellectual contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.

ERRATA AND CORRECTIONS IN PUBLISHED ARTICLES

Authors and readers are encouraged to notify the Editor-in-Chief if they find errors in published content, authors’ names and affiliations or if they have reasons for concern over the legitimacy of a publication. In such cases the journal will publish an ERRATUM in consultation with Editor-in-Chief and authors of the article in the next issue, and/or replace or retract the article.